Navigation Links
Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
Date:8/19/2007

l (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Shire's focused strategy is to develop and market products for specialty physicians. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development, manufacturing and commercialization; the impact of competitive products, including, but not limited to the impact of those on Shire's Attention Deficit and Hyperactivity Disorder ("ADHD") franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine) extended release (ADHD); Shire's ability to secure new products for commercialization and/or development; Shire's ability to benefit from its acquisition of New River Pharmaceuticals Inc.; the successful development of JUVISTA(R) (human TGF BETA 3) and other risks and uncertainties detaile
'/>"/>

SOURCE Shire PLC

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. Im Still Waiting for the Information Age in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Spectrum Blue Steel is emerging as one of the fastest ... of True Green Energy Group and True Green Planet,s President ... recycling business for over 25 years, stated that Spectrum Blue ... the stage for spectacular earnings because of the bi products ...
(Date:12/2/2009)... The world,s first concept demonstration tires ... a petrochemically produced ingredient in the manufacture of synthetic ... Denmark, this week. One tire will be on display ... the Copenhagen International Airport throughout December 21, while the ...
(Date:12/2/2009)... Dec. 2 TechConnect World, an event bringing ... integration in cleantech, nanotech, biotech and MEMS, announced ... business presentations. ,, Now in its 14th year, ... and Technology Institute (NSTI), and the Clean Technology ...
(Date:12/2/2009)... Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... global biopharmaceutical company focused on endocrine therapy and ... Drug Administration (FDA) has granted Fast Track designation ... (KRX-0401), for the treatment of relapsed/refractory multiple myeloma. ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
... ATLANTA, Feb 4 Lentigen Corporation, a biotechnology ... lentiviral gene delivery technologies, and Expression Therapeutics, a ... announced a collaborative agreement to co-develop novel cell ... an inherited blood clotting disorder caused by a ...
... Pharma,(TI Pharma) has formed a consortium with Wageningen University, ... of Schering-Plough, to,develop a ,proof of concept, vaccine against ... of Chikungunya infections. , Viral ... in,recent decades. One of these diseases is caused by ...
... and the American,Pharmacists Association (APhA) Foundation, the creator ... in the Asheville Project(R), have finalized their,partnership to ... Mirixa. MirixaPro(SM) is now the platform of choice ... delivered through,pharmacy. , Announced ...
Other Biology Technology:Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement 2Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement 3Vaccine Against the Chikungunya Virus in Development by a Public-Private Partnership 2Mirixa Corporation and the APhA Foundation Finalize Partnership 2Mirixa Corporation and the APhA Foundation Finalize Partnership 3
(Date:12/3/2009)... past three years in the troposphere (lower atmosphere) over ... which are the first of their kind in the ... 2002 and 2005. , Over recent years, physicists and ... dioxide (CO2) levels, and how these have evolved in ...
(Date:12/3/2009)... low in Antarctic snowmelt that occurred during the 2008-09 ... phases for two main climate drivers, ENSO (El Nio ... according to Dr. Marco Tedesco, Assistant Professor of Earth ... York. , Professor Tedesco, who is also ...
(Date:12/2/2009)... results strengthen the evidence that people who smoke cigarettes ... risk for developing colorectal cancer, even after adjusting for ... reason not to smoke, or to quit as soon ... M.S., vice president emeritus, epidemiology and surveillance research at ...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2American Community Introduces Its Own PPO Network in Ohio to Save Policyholders Money 53220 1American Community Introduces Its Own PPO Network in Ohio to Save Policyholders Money 53220 2Micromet Announces Pricing of Public Offering of Common Stock 13287 1Micromet Announces Pricing of Public Offering of Common Stock 13287 2Micromet Announces Pricing of Public Offering of Common Stock 13287 3Micromet Announces Pricing of Public Offering of Common Stock 13287 4Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53215 1Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53215 2Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53215 3
... engineers from two of the nation,s largest industries medicine ... academicians from the University of Houston, to explore synergies in ... moving oil through a pipeline, the heart must pump blood ... (or blood vessels), free of blockages or corrosion, to function ...
... faster than anywhere else in the world. This is having ... environment and effect of cities on rural areas. One of ... over-looked. , Joy Clancy from the University of Twente has ... African Journal of Ecology . She says "A hundred years ...
... to climate change, pollution and human activity. ESA,s ERS ... the region for the last 17 years. These long ... will be key in implementing the newly adopted European ... Region,. , The policy highlights new opportunities in the ...
Other Biology News:Using the other guy's toolkit: Similarities of pumping blood, oil examined 2ESA satellites focusing on the Arctic 2